跳至主要内容
临床试验/CTRI/2021/09/036747
CTRI/2021/09/036747尚未招募不适用

ROLE OF PRE-OPERATIVE DEXMEDETOMIDINE NEBULISATION 1 VS 2µg/kg IN BLUNTING HAEMODYNAMIC RESPONSE TO LARYNGOSCOPY AND INTUBATION

Dayanand Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 165 人开始时间: 2021年9月29日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
165
试验地点
1
主要终点
•To find most effective dose of nebulised dexmedetomidine with minimal side effect in blunting haemodynamic response to laryngoscopy and intubation by comparing HR, SBP, DBP and MAP at pre-induction, pre-intubation, after-intubation and upto 10 minutes post intubation.

研究概览

简要总结

Dexmedetomidine, a potent, highly selective alpha-2 adrenergic receptor agonist have been used for blunting haemodynamic response to laryngoscopy and intubation through IV, intranasal and nebulised routes. Nebulised dexmedetomidine 1µg/kg effectively blunts increase in heart rate (HR) but not systolic blood pressure (SBP). Dexmedetomidine nebulisation with 2µg/kg dose may help in blunting both tachycardia and hypertensive response.A prospective, randomized, study will be conducted on 150 ASA I and II patients undergoing surgery under general anaesthesia with endotracheal tube (ETT) insertion, who will be divided into 3 groups of 50 patients each. In groups 0, I and II, patients will be nebulised for 10 minutes with 5 ml of 0.9% NaCl solution containing 0, 1 and 2 µg/kg  dexmedetomidine respectively, 10 minutes before induction. Heart rate, Systolic, diastolic and mean arterial pressure (MAP) will be monitored and recorded at regular intervals and the data so collected will be analysed statistically.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
19.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • •Age more than 18 years •ASA I & II patients undergoing surgery under general anaesthesia •Patient with Mallampati class 1 or 2.

排除标准

  • •Pregnant females •Patient with unstable haemodynamics •Predicted airway difficulty •ASA III & IV patients •Known allergy to dexmedetomidine.

结局指标

主要结局

•To find most effective dose of nebulised dexmedetomidine with minimal side effect in blunting haemodynamic response to laryngoscopy and intubation by comparing HR, SBP, DBP and MAP at pre-induction, pre-intubation, after-intubation and upto 10 minutes post intubation.

时间窗: BASELINE, after 5 mins i.e during nebulisation, after 10 mins i.e post nebulusiation, Pre-induction, Pre-intubation, Post intubation and then after every one min till BP and HR comes normal.

次要结局

  • •To compare effect of 1 & 2 μg/kg nebulised dexmedetomidine on reduction of induction dose of propofol.(•To compare incidence and magnitude of complication associated with use of 1 & 2 μg/kg nebulised dexmedetomidine.)

研究者

发起方
Dayanand Medical College and Hospital
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验